Compare NBIX & GL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBIX | GL |
|---|---|---|
| Founded | 1992 | 1900 |
| Country | United States | United States |
| Employees | N/A | 3732 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 11.3B |
| IPO Year | 1996 | N/A |
| Metric | NBIX | GL |
|---|---|---|
| Price | $128.55 | $140.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 11 |
| Target Price | ★ $175.23 | $166.18 |
| AVG Volume (30 Days) | ★ 1.2M | 397.5K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.77% |
| EPS Growth | ★ 41.95 | N/A |
| EPS | ★ 4.67 | N/A |
| Revenue | ★ $161,626,000.00 | N/A |
| Revenue This Year | $22.85 | $9.60 |
| Revenue Next Year | $9.99 | $5.54 |
| P/E Ratio | $27.75 | ★ $10.21 |
| Revenue Growth | ★ 977.51 | N/A |
| 52 Week Low | $84.23 | $109.38 |
| 52 Week High | $160.18 | $152.71 |
| Indicator | NBIX | GL |
|---|---|---|
| Relative Strength Index (RSI) | 42.79 | 40.30 |
| Support Level | $122.82 | $139.97 |
| Resistance Level | $128.99 | $143.04 |
| Average True Range (ATR) | 2.97 | 3.11 |
| MACD | 0.12 | -0.63 |
| Stochastic Oscillator | 23.91 | 15.11 |
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.